Trust Point Inc. Has $467,000 Position in Stevanato Group S.p.A. (NYSE:STVN)

Trust Point Inc. grew its position in Stevanato Group S.p.A. (NYSE:STVN) by 16.0% during the 3rd quarter, HoldingsChannel reports. The firm owned 23,336 shares of the company’s stock after purchasing an additional 3,222 shares during the quarter. Trust Point Inc.’s holdings in Stevanato Group were worth $467,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Hilltop National Bank increased its position in shares of Stevanato Group by 34.3% in the 2nd quarter. Hilltop National Bank now owns 4,395 shares of the company’s stock valued at $81,000 after buying an additional 1,122 shares in the last quarter. PNC Financial Services Group Inc. grew its stake in Stevanato Group by 54.2% in the fourth quarter. PNC Financial Services Group Inc. now owns 3,089 shares of the company’s stock valued at $84,000 after acquiring an additional 1,086 shares during the period. nVerses Capital LLC bought a new stake in shares of Stevanato Group in the third quarter worth about $84,000. Harbor Capital Advisors Inc. increased its holdings in shares of Stevanato Group by 109.1% in the second quarter. Harbor Capital Advisors Inc. now owns 8,867 shares of the company’s stock worth $163,000 after acquiring an additional 4,626 shares in the last quarter. Finally, Raymond James Trust N.A. raised its position in shares of Stevanato Group by 18.7% during the second quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock worth $188,000 after purchasing an additional 1,613 shares during the period.

Stevanato Group Price Performance

NYSE:STVN opened at €18.32 ($19.91) on Friday. The stock has a 50-day simple moving average of €19.81 and a 200 day simple moving average of €21.28. Stevanato Group S.p.A. has a 52-week low of €16.56 ($18.00) and a 52-week high of €34.73 ($37.75). The company has a current ratio of 1.74, a quick ratio of 1.13 and a debt-to-equity ratio of 0.19.

Stevanato Group (NYSE:STVN) last released its quarterly earnings results on Tuesday, August 6th. The company reported €0.09 ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of €0.10 ($0.11) by (€0.01) (($0.01)). The firm had revenue of €259.60 million for the quarter, compared to analyst estimates of €254.92 million. Stevanato Group had a return on equity of 10.89% and a net margin of 11.27%. The company’s revenue was up 1.7% compared to the same quarter last year. During the same period last year, the company earned $0.15 EPS. As a group, sell-side analysts forecast that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

STVN has been the subject of several research analyst reports. Morgan Stanley decreased their price objective on Stevanato Group from $26.00 to $22.00 and set an “equal weight” rating for the company in a research report on Monday, July 15th. Citigroup reduced their price target on shares of Stevanato Group from $30.00 to $28.00 and set a “buy” rating for the company in a report on Wednesday, August 7th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of €29.25 ($31.79).

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.